Integra Lifesciences Holdings (IART) Retained Earnings (2009 - 2026)

Integra Lifesciences Holdings has disclosed Retained Earnings across 18 years of filings, most recently posting $423.3 million for Q2 2026.

• In Q2 2026, Retained Earnings fell 1.68% year-over-year to $423.3 million; the TTM figure through Jun 2026 stood at $423.3 million (down 1.68% YoY), while the FY2025 annual figure was $423.4 million, down 54.95% from the prior year.
• Retained Earnings came in at $423.3 million for Q2 2026 at Integra Lifesciences Holdings, up from $418.8 million in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of $946.9 million in Q4 2023 to a low of $418.8 million in Q1 2026.
• Average Retained Earnings over 5 years is $759.4 million, with a median of $891.2 million recorded in 2022.
• Year-over-year, Retained Earnings rose 27.26% in 2022 and tumbled 54.95% in 2025.
• Over 5 years, Retained Earnings stood at $879.1 million in 2022, then increased by 7.71% to $946.9 million in 2023, then dropped by 0.73% to $939.9 million in 2024, then plunged by 54.95% to $423.4 million in 2025, then retreated by 0.03% to $423.3 million in 2026.
• Per Business Quant data, the three most recent Retained Earnings figures were $423.3 million in Q2 2026, $418.8 million in Q1 2026, and $423.4 million in Q4 2025.